1. Home
  2. Labeler Index
  3. Actavis Pharma, Inc.
  4. 52544-695
  5. NDC Package Code: 52544-695-19 Matzim La

NDC Package 52544-695-19 Matzim La

Diltiazem Hydrochloride Tablet, Extended Release Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
52544-695-19
Package Description:
90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Product Code:
52544-695
Proprietary Name:
Matzim La
Non-Proprietary Name:
Diltiazem Hydrochloride
Substance Name:
Diltiazem Hydrochloride
Usage Information:
Diltiazem is used to treat high blood pressure (hypertension) and prevent chest pain (angina). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. When used regularly, diltiazem can decrease the number and severity of episodes of chest pain from angina. It may help increase your ability to exercise. Diltiazem is called a calcium channel blocker. It works by relaxing blood vessels in the body and heart so blood can flow more easily. Diltiazem also lowers your heart rate. These effects help the heart work less hard and lower blood pressure.
11-Digit NDC Billing Format:
52544069519
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
90 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1091623 - Matzim LA 420 MG 24HR Extended Release Oral Tablet
  • RxCUI: 1091623 - 24 HR diltiazem hydrochloride 420 MG Extended Release Oral Tablet [Matzim]
  • RxCUI: 1091623 - 24 HR Matzim 420 MG Extended Release Oral Tablet
  • RxCUI: 1091623 - Matzim LA 420 MG 24 HR Extended Release Oral Tablet
  • RxCUI: 1091629 - Matzim LA 240 MG 24HR Extended Release Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Actavis Pharma, Inc.
    Dosage Form:
    Tablet, Extended Release - A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • DILTIAZEM HYDROCHLORIDE 420 mg/1
    • Pharmacologic Class(es):
  • Calcium Channel Antagonists - [MoA] (Mechanism of Action)
  • Calcium Channel Blocker - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA077686
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    03-28-2011
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    52544-695-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 52544-695-19?

    The NDC Packaged Code 52544-695-19 is assigned to a package of 90 tablet, extended release in 1 bottle, plastic of Matzim La, a human prescription drug labeled by Actavis Pharma, Inc.. The product's dosage form is tablet, extended release and is administered via oral form.

    Is NDC 52544-695 included in the NDC Directory?

    Yes, Matzim La with product code 52544-695 is active and included in the NDC Directory. The product was first marketed by Actavis Pharma, Inc. on March 28, 2011 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 52544-695-19?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 90.

    What is the 11-digit format for NDC 52544-695-19?

    The 11-digit format is 52544069519. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-252544-695-195-4-252544-0695-19